top of page

The SHAPE Trial Advisory Meeting – Part II


A satellite event in conjunction with

2015 Annual Scientific Sessions of American Heart Associations

November 9th, 7-9PM, Rosen Plaza Hotel, Orlando, FL


7:00 PM

 Opening: Morteza Naghavi, M.D.

  Founder and Executive Chairman of SHAPE


Daniel Berman, M.D.

Director of Cardiac Imaging and of Nuclear Cardiology at Cedars-Sinai,
Los Angeles, CA

Mathew Budoff, M.D.

Professor of Medicine and Director of Preventive Cardiology, UCLA Harbor, Los Angeles, CA

Summary of Part-I SHAPE Trial Advisory Meeting
(Design and Fundraising)

David Maron, M.D. Morteza Naghavi, M.D.

1- ROBINSCA original
2- Modified ROBINSCA with a CAC zero subgroup to test “Power of Zero”
4- Modified PRECISION with a CAC zero subgroup to test “Power of Zero”
5- HRP / BioImage? Google Baseline? VIEW? or a completely new study design?

Design and Implementation of ROBINSCA
(Risk of Benefit in Screening for Cardiovascular Disease

H.J. de Koning, M.D., Ph.D. and Matthijs Oudkerk, M.D., Ph.D.

Click here to view agenda for both sessions

bottom of page